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Background: Sterile inflammation occurs in the absence of live pathogens and is an unavoidable consequence of
ischemia-reperfusion (IR) injury in the central nervous system (CNS). It is known that toll-like receptor 4 (Tlr4) contributes
to damage and sterile inflammation in the CNS mediated by IR. However, the mechanism of Tlr4 activation under
sterile conditions in ischemic tissue is poorly understood. We performed this study to clarify the mechanism. To this
end, we focused on the extracellular heat shock protein 70 (Hsp70), the prototypic Tlr4 ligand.
Methods: Tlr4-, Myd88- and Trif-knockout animals, as well as C57BL/6 mice, were used for the wild type control. For
the in vivo study, we used a mouse model of retinal IR injury. To test the role of protein kinase C (PKC) in IR injury,
IR retinas were treated with the PKC inhibitors (polymyxin B and Gö6976) and retinal damage was evaluated by directly
counting neurons in the ganglion cell layer of flat-mounted retinas seven days after IR. Primary retinal neurons (retinal
ganglion cells) and glial cells were used for in vitro experiments. Quantitative RT-PCR, ELISA and western blot analysis
were used to study the production of pro-inflammatory factors in IR retinas and in primary cell cultures.
Results: We found significant accumulation of extracellular Hsp70 in a model of retinal IR injury. We noted that PKC
was involved in Tlr4 signaling, and found that PKC inhibitors promoted neuroprotection by reducing pro-inflammatory
activity in ischemic tissue. To put all of the pieces in the signaling cascade together, we performed an in vitro study.
We found that PKC was critical to mediate the Hsp70-dependent pro-inflammatory response. At the same time,
the contamination of Hsp70 preparations with low-dose endotoxin was not critical to mediate the production
of pro-inflammatory factors. We found that extracellular Hsp70 can promote neuronal death at least, by mediating
production of cytotoxic levels of tumor necrosis factor alpha, predominantly due to the Tlr4/Myd88 signaling cascade.
Conclusions: Our findings suggest that PKC acts as a switch to amplify the pro-inflammatory activity of Hsp70/Tlr4
signaling, which is sufficient to mediate neuronal death.
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Sterile inflammation, characterized by innate immune re-
sponses in tissue, occurs in the absence of live pathogens,
is a pathologic hallmark of ischemia-reperfusion (IR) in-
jury in the central nervous system (CNS), and is spatio-
temporally related to delayed neuronal death [1-3]. It has
been reported that endogenous ligands (damage-associ-
ated molecular patterns (DAMPs)) liberated from IR in-
jured cells act through pattern recognition receptors,
initiating an innate immune response in tissue [4-9]. Toll-
like receptor 4 (Tlr4) is a pattern recognition receptor that
initiates an innate immune response in the presence of ex-
ogenous (bacteria-derived endotoxins) and endogenous
(DAMPs) ligands [9,10]. Tlr4 plays a critical role in medi-
ating CNS sterile inflammation and tissue damage trig-
gered by IR [11,12]. However, the mechanism by which
DAMPs activate Tlr4 was not understood. This issue cre-
ates evident challenges for the development of drugs that
are effective against IR injury.
Currently, there are conflicting results regarding whether
or not DAMPs can directly activate Tlr4. While it was
shown that DAMPs or their modifications can directly ac-
tivate Tlr4 [3,9,13,14], there is evidence that DAMPs can
initiate an innate immune response acting in synergy with
low-dose endotoxin [15-17]. Since the presence of low
endotoxin levels has been reported in many tissues, includ-
ing the CNS [18-21], it could be possible that DAMPs re-
leased after IR combine with endotoxins and cooperate to
initiate a pro-inflammatory response that promotes neur-
onal death and tissue damage. At the same time, many of
the studies that argue that DAMPs work with endotoxins
use an endotoxin inhibitor named Polymyxin B (PMB)
[22]. It is important to note that PMB is also a protein kin-
ase C (PKC) inhibitor [23-25]. It is known that PKC acts at
multiple steps of toll-like receptor signaling, promoting
an innate immune response in tissue [26]. Thus, DAMP-
dependent pro-inflammatory toxicity in ischemic tissue
could be due to PKC activity. In this study, we explore
whether DAMPs released after IR promote neuronal tox-
icity alone, because of endotoxin presence, or as a result of
PKC activity. To figure out an answer, we focused on the
extracellular heat shock protein 70 (Hsp70), the prototypic
DAMP molecule and ligand of Tlr4 [3,9,14]. Our findings
suggest that Hsp70 released after IR can initiate innate
immune-mediated neurotoxicity in a PKC-dependent man-
ner. These findings also propose that the presence of low
endotoxin levels in Hsp70 preparations is not critical in
mediating the production of pro-inflammatory factors.
Methods
Materials
All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, Missouri, United States, Life Technologies
(Grand Island, New York, United States), Thermo Scientific(Rockford, Illinois, United States) and Lonza (Walkersville,
Maryland, United States). Polymyxin B sulfate was pur-
chased from Santa Cruz Biotechnology (Dallas, Texas,
United States), recombinant low endotoxin HSP70 (Cat#
ADI-ESP-555-F, < 50 EU/mg purified protein) was purchased
from Enzo Life Sciences (Farmingdale, New York, United
States). RAW-BlueTM cells (RAW264.7 macrophages
stably transfected with the NF-κB reporter gene) were
purchased from InvivoGen (San Diego, California, United
States). Lipopolysaccharides (LPS) from Escherichia coli
0111:B4 were purchased from Sigma-Aldrich (St. Louis,
Missouri, United States).
Animals
All experiments and postsurgical care were performed in
compliance with the National Institutes of Health (NIH)
Guide for the Care and Use of Laboratory Animals and
according to the University of Miami Institutional Animal
Care and Use Committee (IACUC) approved protocols.
Tlr4-, Myd88-, and Trif-deficient animals (stock numbers
007227; 009088, 005037) and C57BL/6 J (stock number
000664) mice as the wild type (WT) control were obtained
from the Jackson Laboratory (Bar Harbor, Maine, United
States). Mice were housed under standard conditions of
temperature and humidity, with a 12 hour light to dark
cycle and free access to food and water. All animals used
in our experiments were either 3-month old male mice, or
3 or 12-day old pups.
Transient retinal ischemia
Anesthesia was induced with isoflurane and maintained
for 45 minutes. Anesthetics were administered to the
breathing animals through a tightly fitting nose cone. Body
temperature was held constant at 37°C with a temperature-
controlled heating pad. After anesthesia, pupils were dilated
with 1% tropicamide to 2.5% phenylephrine hydrochloride
(NutraMax Products Inc., Gloucester, Massachusetts,
United States), and corneal analgesia was achieved with
one drop of 0.5% proparacaine HCl (Bausch and Lomb
Pharmaceuticals, Tampa, Florida, United States). Retinal
ischemia was induced for 45 minutes by introducing into
the anterior chamber of the left eye a 33-gauge needle
attached to a normal (0.9% NaCl) saline-filled reservoir
raised above the animal in order to increase intraocular
pressure (IOP, increased to 120 mmHg). The contralateral
eye was cannulated and maintained at normal IOP to
serve as a normotensive control. Complete retinal ische-
mia, evidenced by a whitening of the anterior segment
of the eye and blanching of the retinal arteries, was verified
by microscopic examination. After the needle was removed,
erythromycin ophthalmic ointment (Fera Pharmaceuticals,
Locust Valley, New York, United States) was applied to the
conjunctival sac. Mice were euthanized by CO2 inhalation
under anesthesia.
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Mice were injected intraperitoneally (IP) with either
PMB (8 μg/g body of mouse) or Gö6976 (167 ng/g body
of mouse it is fine to leave as is) one hour before ische-
mia, six hours after surgery, and twice every twenty four
hours until they were euthanized. Control animals were
treated with phosphate-buffered saline (PBS). To evalu-
ate the real concentration of PMB and Gö6976 in the
retina, we performed the following calculations. After
the IP injection, the drug was distributed throughout the
animal’s body and accumulated in the tissues and or-
gans. Thus, we had to take into account the volume of
the whole animal body in our calculations. The average
volume of the adult mice used in our study was 30 ml
(we used Archimedes’ principle to measure this volume,
by immersing the body of the mouse in water and meas-
uring volume of water displacement, which equals volume
of the mouse’s body)). To calculate the PMB concentra-
tion, we took into account: 1) mouse volume = 30 ml;
2) PMB molecular weight = 1301.56 g/mol; 3) we injected
8 μg of PMB per 1 g of mouse; 4) average mouse weight =
30 g. Thus, we injected a total of 240 μg of PMB per
one injection (30 (g) × 8 (μg of PMB per 1 g of mouse) =
240 μg). We injected 240 × 10−6 (g of PMB)/1301.56
(g/mol) = 1.84 × 10−7 mol. Therefore, the concentration
was 1.84 × 10−7 (mol)/(30 × 10−3 L) = 6.1 × 10−6 (mol/L) =
6 μM. However, we took into account that the total water
content of the mouse was about 80%, and so the final
concentration was 7.5 μM. By performing similar cal-
culations and considering that Gö6976’s molecular weight
was 378.43 g/mol, we calculated the final concentration
of Gö6976, which was equal to 551 nM. Importantly,
since mice were injected intraperitoneally (IP) twice every
twenty four hours until they were euthanized seven days
later (after reperfusion), the real concentration of PMB
and Gö6976 in the retina could be higher.
Immunohistochemistry
Eyes were enucleated upon euthanasia, incised at the ora
serrate, and immersion-fixed in 4% PF. After one hour,
the retinas were removed and cryoprotected overnight
in 30% sucrose. The following day, the retinas underwent
three freeze–thaw cycles, were rinsed 3 × 10 minutes in
0.1 M Tris buffer, were blocked by 5% donkey serum and
0.1% Triton X-100 in 0.1 M Tris buffer for one hour, and
were then incubated overnight with either monoclonal
FITC–conjugated neuronal nuclei (NeuN) antibody (1:300;
Chemicon, Billerica, Massachusetts, United States) or beta
III Tubulin antibody (1:250; Covance, Denver, Pennsylva-
nia, United States). After 3 × 10 minutes rinsing in 0.1 M
Tris buffer, the retinas were flat-mounted, cover-slipped,
and imaged using a Leica TSL AOBS SP5 confocal micro-
scope (Leica Microsystems, Exton, Pennsylvania, United
States).Counting of ganglion cell layer neurons
NeuN- or beta III Tubulin-positive neurons in the gan-
glion cell layer (GCL) were imaged by confocal micros-
copy in flat-mounted retinas. Individual retinas were
sampled randomly to collect a total of 20 images from
four retinal quadrants using a 20× objective lens. Five
images were collected from each quadrant: one from the
center, two from the middle, and two from the periph-
eral regions of the retina. NeuN-positive neurons were
counted using ImageJ software. This software counts
cells semi-automatically, meaning that it records the
number of cells that are clicked on by the person identi-
fying cells in the image. Cell loss in the ischemic retinas
was calculated as a percentage of the mean cell density
in normotensive fellow control eyes.
NF-κB reporter assay
RAW-Blue cells (RAW264.7 macrophages stably expressed
a secreted embryonic alkaline phosphatase gene inducible
by NF-κB and resistant to the selectable marker Zeocin)
were seeded in 96-well plates in test medium (DMEM,
4.5 g/l glucose, 10% heat-inactivated FBS, 100 mg/ml
Normocin™, 2 mM L-glutamine) at a density of 4 × 105
cells/ml and grown overnight in a 5% CO2 incubator at
37°C. After treated as indicated, the medium was har-
vested, and 20-μl samples were mixed with the QUANTI-
Blue™ (InvivoGen, San Diego, California, United States)
medium (200 μl) in 96-well plates at 37°C for 15 minutes,
and the optical density at 655 nm was measured on a
Multiskan microplate spectrophotometer (Thermo Scien-
tific, Brookfield, Wisconsin, United States).
Primary cultures of retinal ganglion cells, astrocytes and
microglia
To isolate retinal ganglion cells (RGCs), we used the two-
step immunopanning protocol [8,27]. To this end, the ret-
inas were incubated in papain solution (16.5 U/mL) for
30 minutes. Next, macrophage and endothelial cells were
removed from the cell suspension by panning with the
anti-macrophage antiserum (Accurate Chemical, Westbury,
New York, United States). RGCs were bound to the pan-
ning plates containing anti-Thy1.2 antibody and re-
leased by trypsin incubation. Isolated primary RGCs were
grown in serum-free media (Neurobasal/B27 media; Life
Technologies, Grand Island, New York, United States)
one day before the experiment. Astrocytes and microglial
cells were obtained by the ‘shaking method’ as previously
described [28]. These cells were cultured in DMEM (Life
Technologies, Grand Island, New York, United States) con-
taining 10% heat-inactivated fetal bovine serum (FBS)
(Life Technologies, Grand Island, New York, United States)
one day before the experiment. Astrocytes and microglial
cells were maintained during the experiment in DMEM
containing 0.1% FBS. To prepare RGC/glia co-culture,
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plated in culture inserts and placed into the culture wells
containing RGCs 24 hours prior to treatment. RGC/glia co-
cultures containing 0.1% FBS were maintained during the
experiment in DMEM.
Neuronal death assay
After treatment, dead neurons were determined using a
kit (Vybrant Apoptosis Assay Kit #2; Life Technologies,
Grand Island, New York, United States). Cells were im-
aged using a confocal microscope (Leica TSL AOBS SP5;
Leica Microsystems, Pennsylvania, United States). Individ-
ual glasses were sampled randomly to collect a total of 10
images using a 20X objective lens. The dead RGCs were
counted using ImageJ software. The percentage of dead
RGCs relative to the total number of cells was determined.
The experiment was repeated at least three times.
Quantitative reverse transcription polymerase chain
reaction (RT-PCR) analysis
To perform quantitative RT-PCR analysis using gene-
specific primers (Table 1), total RNA was extracted from
retinas and primary cell cultures using Absolutely RNA
Nanoprep or Microprep kits (Agilent Technologies, Santa
Clara, California, United States) and reverse transcribed
with the Reverse Transcription System (Promega, Madison,
Wisconsin, United States) to synthesize cDNA. Quantita-
tive PCR was performed in the Rotor-Gene Q Cycler
(Qiagen, Valencia, California, United States) using the
SYBR GREEN PCR MasterMix (Qiagen, Valencia, California,
United States). For each gene, relative expression was
calculated by comparison with a standard curve, following
normalization to the housekeeping gene β-actin (Actb)
and succinate dehydrogenase subunit A (Sdha) expression
chosen as controls.
Western blot analysis
Astrocyte monolayers were lysed with RIPA (named after its
original application, radio-immunoprecipitation assay) buffer
supplemented with complete protease inhibitor (Roche
Applied Science, Indianapolis, Indiana, United States).
Protein concentration was assessed using the BCA kit
(Thermo Scientific, Brookfield, Wisconsin, United States).
An equal amount of total protein from each sample
was resolved on SDS-PAGE gradient gels and trans-
ferred to PVDF (polyvinylidene fluoride) membrane (Life
Technologies, Grand Island, New York, United States).
Blots were blocked in 5% milk in Tris-buffered saline
(TBS, pH 7.6), probed with the primary antibody against
Il1b (1:1,000, Abcam, Cambridge, Massachusetts, United
States) overnight, washed in 0.15% Tween20 in TBS, and
incubated for one hour with secondary antibody (1:10,000,
Amersham Biosciences, New Jersey, United States) diluted
in TBS. Anti-β-actin antibodies were used to control theloading. Proteins were visualized using SuperSignal chemi-
luminescent substrates (Thermo Scientific, Brookfield,
Wisconsin, United States) and quantified using the FUJIFILM
software (Fujifilm, www.fujifilm.com).
Enzyme-linked immunosorbent assay (ELISA)
The amount of Tnf and Il1b in culture media was deter-
mined by using mouse Tnf-specific, and mouse Il1b-
specific ELISA kits (eBioscience, San Diego, California,
United States) according to the manufacturer’s protocols.
The amount of Hsp70 in the vitreous humor was mea-
sured by using a mouse Hsp70-specific ELISA kit (Enzo
Life Sciences, Farmingdale, New York, United States). The
determination of the protein levels was performed accord-
ing to the manufacturer’s protocols.
Measurement of Hsp70 levels in the vitreous humor
It is known that the volume of vitreous humor in the mouse
eye is 5.3 μl [29]. To collect the vitreous humor (VH), the
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point temporal and posterior to the limbus, behind the
lens. A small drop of VH that drained out was collected.
This collected volume was equal to 2.5 μl, which was
transferred in the tube containing 22.5 μl of PBS. Thus,
the VH content was diluted tenfold. The tube was centri-
fuged at 1100 RPM for 15 minutes at +4°C and the super-
natant was collected. To evaluate the Hsp70 level, ten
microliters of the supernatant were added to 90 μl of
ELISA buffer and the 100 μl were used for ELISA analysis.
Therefore, the VH content was diluted tenfold a second
time and the final dilution factor was 100. The measured
Hsp70 levels were multiplied by 100, which gave us the
final concentrations. To evaluate Hsp70 concentration
in the GCL, we made the following assumptions: 1) GCL
thickness is 30 μm, retinal area is 15.6 mm2 [29], so the
GCL volume (VGCL) was 468*10
−6 ml; 2) only half of
Hsp70 proteins released after IR are diffused in VH from
GCL; 3) efficiency of Hsp70 penetration from the GCL to
the VH due to the inner limiting membrane (the border
between the VH and the retina) is 10 to 50% (1/10 ÷ 1/2).
Intravitreal injection
Intravitreal injections were performed under a microsur-
gical microscope using glass pipettes with a diameter of
approximately 150 μm at the tip. The left eye was punc-
tured at the upper nasal limbus and a volume of 1 μl of
Hsp70 (1 μg per injection) was injected. The contralat-
eral eye was injected with a vehicle (control). To allow
the solution to diffuse, the pipette was kept in place for
about 15 seconds.
Detection of endotoxins
All equipment, glassware, and materials used in the fol-
lowing procedures were either purchased as endotoxin-
free or had been made endotoxin-free by heating at
250°C for 30 minutes. We took into account that the
mean retinal thickness is 210 μm and retinal area is
15.6 mm2 [29]. Thus, retinal volume (Vr) was 3.276 μl. To
measure endotoxin levels, 84 μl of endotoxin-free water
was added to 20 retinas (66 μl). Then, three cycles of
freezing in a liquid nitrogen bath and thawing in a 100°C
water bath, followed by vortexing until tissue had dis-
solved as much as possible, were performed. The result-
ing tissue homogenates were centrifuged for 15 minutes
at maximum speed and supernatants were collected. In
order to evaluate the endotoxin level, 100 μl of the super-
natant were used to measure the endotoxin by using the
PYROGENT™ Ultra Gel Clot LAL (0.03 EU/ml sensitiv-
ity) assay, as recommended by the manufacturer (Lonza,
Walkersville, Maryland, United States). To prepare serum,
the blood was collected from the heart and allowed
to clot by leaving it undisturbed at room temperature
(30 to 60 minutes). The clot was removed by centrifugingat maximum speed for 15 minutes in a refrigerated centri-
fuge. The resulting supernatant (serum) was transferred
into new endotoxin-free tubes and frozen at -80°C. All
culture media were processed using a sterile technique
and stored at -80°C prior to assays. The PYROGENT™
Ultra Gel Clot LAL (0.03 EU/ml sensitivity) assay was per-
formed as recommended by the manufacturer (Lonza,
Walkersville, Maryland, United States). To determine the
endotoxin concentration, we tested serial two-fold dilu-
tions of samples until an endpoint was reached.
Statistical analysis
Statistical analysis was performed with a one-way ana-
lysis of variance (ANOVA) followed by the Tukey test
for multiple comparisons. In the case of single compari-
sons, the Student’s t-test was applied. P values equal to
or less than 0.05 were considered statistically significant.
Results
Polymyxin B mediates neuroprotection after ischemia-
reperfusion injury due to protein kinase C inhibition
rather than endotoxin inhibition
Necrosis is a pathologic hallmark of IR injury in the
CNS [4-7]. Retinal IR injury results in a prolonged
period of cell death with a high level of necrosis at the
early stage of pathology [4,5,30]. We have previously
demonstrated that the release of DAMPs, as a result of
retinal necrosis and Tlr4 signaling, contributes to IR-
induced retinal injury [5,8,11]. Thus, the retinal ischemia
model was the most suitable model to achieve the objec-
tives of this study. We first asked whether endotoxins
play a role in IR-induced retinal injury. To answer this
question, we used PMB, a known inhibitor of endotoxin
activity [22]. Mice were injected IP with PMB (8 μg/g
body of mouse or 7.5 μM) or PBS (control) one hour be-
fore IR, six hours after surgery, and twice every twenty
four hours until they were euthanized seven days later,
after reperfusion. Whole retina flat-mounts were stained
for the neuronal marker NeuN to quantify the number
of surviving neurons in the GCL. We found that retinas
from the experimental eyes of PBS-treated mice had sig-
nificantly lower numbers of surviving NeuN-positive neu-
rons in the GCL compared to PMB-treated mice (51 ± 5%
versus 87 ± 4%, P < 0.01) (Figure 1). To evaluate the mo-
lecular changes associated with resistance to IR injury in
PMB-treated retinas, we investigated the activation of
several pro-inflammatory markers known to be involved in
IR-induced cytotoxicity. We compared gene expression in
ischemic versus sham-operated eyes for both PBS- and
PMB-treated mice. We found transcriptional up-regulation
of cytokines (Tnf, Il1b), chemokines (Ccl2, Ccl5, and
Cxcl10), cell adhesion molecule (Icam1), as well as genes
encoding subunits of the reactive oxygen species-producing
NAD(P)H oxidase, in all experimental eyes at both 6 and
Figure 1 Treatment with PMB and Gö6976 results in neuroprotective effects in the GCL after IR: A) Percentage of GCL neurons lost at one
week following IR of C57bl/6 mice treated with PMB, Gö6976, and PBS (control) (**P < 0.01, *P < 0.05, n = 5-7). B) Representative confocal images
of NeuN-labeled GCL (green) neurons in flat-mounted retinas in sham-operated controls and ischemic retinas 7 days after reperfusion. GCL, ganglion
cell layer; IR, ischemia reperfusion; NeuN, neuronal nuclei; PBS, phosphate buffered saline; PMB, polymyxin B.
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however, the expression of Tnf, Il1b, Ccl2, Cxcl10, Icam1,
Ccl2, Cxcl10, and subunits of NAD(P)H oxidase Cybb
(Nox2) and Ncf2 was reduced relative to PBS-treated mice
(Figure 2). One interpretation of these data is that PMB
promotes neuroprotection by reducing pro-inflammatory
activity in ischemic tissue.
The next step in our study was to detect endotoxin
levels in the retina. To evaluate the endotoxin levels in
the retina, we used a gel clot LAL assay kit with sensitivity
of 0.03 EU/ml (since 1 EU = 100 pg, then 0.03 EU/ml = 3
pg/ml). We collected and analyzed endotoxin levels in
three groups containing 20 retinas each. Surprisingly, we
did not detect a positive reaction for any of the three
groups using the gel clot LAL assay. Since the presence of
endotoxins in the blood can affect endotoxin levels in the
retina after IR due to blood-retinal barrier breakdown, we
also attempted to determine the level of endotoxins in
serum, but did not find detectable levels of circulating en-
dotoxins. Given that PMB functions by inhibiting endo-
toxins and the fact that we did not detect endotoxins,
these data suggested that the observed PMB effect in is-
chemic tissue was probably not due to endotoxin pres-
ence. To explain the PMB effect in absence of endotoxins,
we noted that PMB is also a PKC inhibitor (IC50, 2-10
μM) [23-25]. Our calculations, presented in the ‘Methods’
section, indicated that the concentration of PMB in
the retina was at least 7.5 μM. Thus, we asked whether or
not PMB’s neuroprotection could be due to PKC inhib-
ition in ischemic tissue. To test this hypothesis, we used
a PKC inhibitor (Gö6976), which selectively inhibits
Ca2+-dependent PKC isozymes similar to PMB. The ani-
mals were treated with Gö6976 (167 ng/g body of mouse
or 551 nM) IP one hour before ischemia, six hours after
surgery, and twice every twenty four hours until they were
euthanized. Control animals were treated with PBS. After
seven days, the retinas were collected and stained for the
neuronal marker NeuN, and the percentage of survivingGCL neurons was revealed. We found that the percentage
of surviving GCL neurons in the IR retinas was signifi-
cantly higher in mice injected with Gö6976 (71 ± 6%)
compared with those injected with PBS (51 ± 5%, P < 0.05)
(Figure 1). Collectively, these data suggest that perhaps
the observed PMB-induced protection was due to PKC in-
hibition, rather than its endotoxin inhibiting function.
Presence of protein kinase C but not endotoxins critical
to mediate Hsp70-dependent pro-inflammatory response
To study in detail the observed effects in our model, we
needed to identify Tlr4 ligands, which can initiate a pro-
inflammatory response. Since Hsp70 is a Tlr4 ligand that
can stimulate Tlr4 downstream pro-inflammatory effects,
we tested whether Hsp70 is released in the extracellular
space after IR injury. We measured Hsp70 levels in the
VH of the eye 6 and 24 hours after IR injury in the retina
by using the mouse Hsp70-specific ELISA kit (Figure 3).
We observed an increase in Hsp70 protein content in the
VH of ischemic eyes 6 hours (78 ± 17 ng/ml) and 24 hours
(45 ± 13 ng/ml) after reperfusion compared to sham-
operated controls (0 ± 0 ng/ml and 2 ± 2 ng/ml). Thus,
our data indicated that Hsp70 concentration in the VH of
ischemic eyes was in the range of 50 to 100 ng/ml. Since
VH volume is approximately 5.3 μl in mice [29], the quan-
tity of Hsp70 in the VH is estimated to be 265 to 530 pg.
Since only half of Hsp70 proteins are diffused in the VH
from the GCL, the GCL may contain 530 to 1060 pg
of Hsp70. However, since there is the inner limiting
membrane between the VH and the GCL that poses a
barrier for penetration of Hsp70 into the VH from the
GCL, the actual quantity of the extracellular Hsp70 in
the GCL should be in the range of 1-10 ng (Methods). Since
GCL volume is 468*10−6 ml (Methods), the real concentra-
tion of Hsp70 in GCL after IR should be in the range
of 2 ÷ 20 μg/ml. Based on these data, we evaluated
the minimum concentration of Hsp70 required to ini-
tiate a pro-inflammatory response. To figure this out,
Figure 3 Extracellular Hsp70 is accumulated in the vitreous humor of animals suffering from retinal ischemia: A) Level of Hsp70 in
vitreous humor of sham-operated and ischemic eyes 6 and 24 hours after reperfusion. B) Representative western blot. h, hours; Hsp70, heat shock
protein 70; IR, ischemic reperfusion.
Figure 2 PMB treatment reduces pro-inflammatory gene expression following IR injury. Differential expression of cytokines, chemokines,
cell adhesion molecules, as well as genes encoding Nos2 and subunits of the reactive oxygen species-producing NAD(P)H oxidase was assessed
in sham-operated and ischemic retinas of PMB- and PBS-treated animals, 6 and 12 hours after reperfusion, by using quantitative RT-PCR. For each
gene, results are expressed as a percentage of corresponding value in the sham-operated eye of PBS-treated animals (*P < 0.05, **P < 0.01, five animals
per group). IR, ischemia reperfusion; PBS, phosphate buffered saline; PMB, polymyxin B.
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which, upon Tlr4 stimulation, initiates NF-κB-dependent
production and secretion of easily detectable and measur-
able embryonic alkaline phosphatase (SEAP). The RAW-
blue cells were treated with recombinant Hsp70 protein.
When we first measured endotoxin levels in culture media
containing the recombinant Hsp70, we found that 10 μg/ml
of Hsp70 contains 3 pg/ml (0.03 EU/ml) of endotoxins.
Measuring the level of SEAP in the media of Hsp70 treated
RAW-blue cells, we have detected that the combination of
5 μg/ml of Hsp70 and 1.5 pg/ml (0.015 EU/ml) of endo-
toxins is enough to activate NF-κB (Figure 4). We also
found that heat inactivation of Hsp70 significantly reduced
SEAP production in RAW-blue cells.
Next, we investigated the Hsp70-dependent pro-
inflammatory response of glial cells, because their activa-
tion was shown to occur temporally before leukocyte
infiltration in ischemic retina. Glial cells (astrocytes and
microglia) were isolated from WT and Tlr4 knockout ani-
mals (Tlr4KO) and treated for 24 hours with 5 μg/ml of
Hsp70 containing 1.5 pg/ml (0.015 EU/ml) of endotoxins.
We observed increased levels of cytokine, chemokine,
NAD(P)H oxidase, and nitric oxide synthase activity in
Hsp70-treated glial cells compared to the PBS-treated
control (Figure 5). This activity was significantly reducedFigure 4 Stimulation of RAW-blue reporter cell line with Hsp70
leads to an increase in NF-κB activation. denHsp70 samples were
heated for one hour at 56°C before treatment of cell cultures. Hsp70,
heat shock protein 70; PBS, phosphate buffered saline.in glial cells isolated from Tlr4KO animals (Figure 5) as
well as in glial cells treated with heat-inactivated Hsp70
(Figure 5). Next we asked the question of whether such
low detected levels of endotoxins can alone initiate a pro-
inflammatory response. To answer this question, we tested
the pro-inflammatory activation of glial cells at different
concentrations of LPS. Since we observed a similar pro-
inflammatory response of astrocytes and microglial cells
upon Hsp70 treatment, the experiments were carried out
on primary astrocytes isolated from wild type animals. We
found that 2.5 ng/ml of LPS mediated pro-inflammatory
activation of astrocytes, while 250 pg/ml of LPS had no
stimulatory effects upon astrocytes (Figure 6). Thus, de-
tected low endotoxin levels either play no role or can only
amplify Hsp70 pro-inflammatory effects.
To answer the question of whether the detected low
endotoxin levels affect pro-inflammatory activity of Hsp70,
we performed an additional series of experiments using
PMB. The primary astrocytes were treated 24 hours with
5 μg/ml of Hsp70 containing 1.5 pg/ml of endotoxins,
LPS (2.5 ng/ml) in the presence or absence of PMB (1 and
10 μg/ml). The cells were lysed after 24 hours and tran-
scriptional levels of cytokines and chemokines were ana-
lyzed using quantitative PCR. We also tested the Tnf level
in the media of treated cells using a mouse Tnf-specific
ELISA kit. We found that the pro-inflammatory response
of LPS-treated astrocytes was significantly reduced by
the addition of 1 μg/ml (0.7 μM) of PMB (Figure 7A).
At the same time, Hsp70–treated astrocytes in the pres-
ence of 1 μg/ml (0.7 μM) of PMB did not reduce but rather
increased expression of the cytokines and chemokines
(Figure 7A). We also found that the level of Tnf in
culture media from LPS/PMB-treated cells was signifi-
cantly reduced, while the level of Tnf in culture media
from Hsp70/PMB-treated cells was just slightly/insignifi-
cantly reduced (Figure 7B). However, treatment of cell cul-
tures with 10 μg/ml (7 μM) of PMB significantly reduced
expression levels of tested cytokines and chemokines in
astrocytes mediated by Hsp70 and LPS (Figure 7A). Inter-
estingly, we were still able to detect Tnf in media from
PMB- (10 μg/ml or 7 μM) and Hsp70-treated cells, while
presence of Tnf in media from PMB- (10 μg/ml or 7 μM)
and LPS-treated cells was not detected (Figure 7B). It
should be recalled that PMB inhibits PKC with an IC50
equal to 2-10 μM [23-25]. Thus, Hsp70-activated cells be-
have as if PMB inhibits only PKC and the presence of low
levels of endotoxins does not play a role, while LPS-
activated cells behave as if PMB inhibits LPS and PKC. It
was shown previously that PKC activation is critical in
LPS-mediated production of pro-inflammatory factors by
macrophages [26]. To test the role of PKC in Hsp70-
dependent pro-inflammatory response, astrocytes were
treated with Hsp70 in the presence or absence of PKC in-
hibitor (Gö6976, 10 nM and 100 nM). After 24 hours,
Figure 5 Hsp70 mediates production of pro-inflammatory factors in a Tlr4-dependent manner. A) Differential expression of cytokines,
chemokines, as well as genes encoding Nos2 and subunits of the reactive oxygen species-producing NAD(P)H oxidase was assessed in primary
cultures of astrocytes and microglia isolated from wild type (WTa and WTm referred to WT astrocytes and WT microglia) and Tlr4KO animals
(Tlr4KOa and Tlr4KOm referred to Tlr4KO astrocytes and Tlr4KO microglia), and treated with Hsp70 (5 μg/ml) containing 1.5 pg/ml of endotoxins
and PBS (control) during a 24-hour period. For each gene, results were expressed as a percentage of the corresponding value in the wild type
astrocytes (WTa) treated with PBS (**P < 0.01, n = 6). B) The amount of Tnf in culture media from astrocytes and microglia isolated from wild type
and Tlr4KO mice and treated with Hsp70 were determined by using mouse Tnf-specific ELISA kits. (**P < 0.01, n = 6). C) Hsp70 induces production
of the immature form of Il1b, but not the active form of Il1b in astrocytes. The astrocytes isolated from wild type and Tlr4KO animals were treated
with Hsp70 (5 μg/ml) and lysed after 24 hours. Forms of Il1b were analyzed by western blot analysis. D) Heat inactivation of recombinant Hsp70
significantly reduced pro-inflammatory response of treated primary astrocytes. Primary astrocytes were treated for 24 hours with recombinant
Hsp70 (5 μg/ml), heat-inactivated recombinant Hsp70 (5 μg/ml), and PBS as a control (**P < 0.01, n = 6). For each gene, results are expressed as a
percentage of corresponding value in the astrocytes treated with PBS (control) (denHsp70 samples were heated for one hour at 56°C before
treatment of cell cultures). Hsp70, heat shock protein 70; PBS, phosphate buffered saline; WT, wild type.
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tected using the ELISA kit. We found that the level
of Tnf was significantly reduced in Gö6976-treated cells
(Figure 7C). Collectively, these data suggest that PKC is
critical to mediate the Hsp70-dependent pro-inflammatory
response. At the same time, the presence of low endotoxin
levels in Hsp70 preparations is not critical in mediating the
production of pro-inflammatory factors. Importantly, PMB
in Hsp70-treated cultures behaves as a PKC inhibitor.
Extracellular Hsp70 mediates Tnf-dependent neuronal death
Changes in the levels of intracellular and extracellular
Hsp70 can produce different responses after IR injury:intracellular Hsp70 mediates neuroprotection after IR
[31,32], while our results indicate that extracellular Hsp70,
providing that PKC is activated, should induce a strong
neurotoxic pro-inflammatory response in tissue. Thus,
interplay between pro-survival and death-promoting
signaling cascades can continue until one eventually
dominates and determines the cell’s fate. We propose
that a high level of extracellular Hsp70 released as a
result of ischemic stress initiates a severe neurotoxic
pro-inflammatory response, which far exceeds Hsp70 neu-
roprotective activity and finally mediates neuronal death.
To test this hypothesis, we first determined the concentra-
tion of Hsp70, which can mediate RGC death in RGC/glia
Figure 6 Astrocytes respond differently to varying concentrations of LPS. Stimulation of primary astrocytes with 2.5 ng/ml of LPS leads to
increased expression of pro-inflammatory genes, while the pro-inflammatory response of primary astrocytes treated with 0.25 ng/ml was
insignificant. Gene expression was assessed in primary astrocytes treated 24 hours with LPS and PBS (controls) by quantitative RT-PCR. For
each gene, results were expressed as a percentage of the corresponding value in the astrocytes treated with PBS. LPS, lipopolysaccharides;
PBS, phosphate buffered saline.
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24-well plate and glial cells (50% primary astrocytes and
50% microglial cells) plated in culture inserts were placed
into the culture wells containing RGCs prior to Hsp70
treatment. These co-cultures were treated with 5 μg/ml
and 20 μg/ml of Hsp70. The level of RGC death was
assessed after 24 hours. Quantification of RGC death
showed significantly higher cell death in cultures treated
with Hsp70 than with PBS (Figure 8A). However, when
RGC loss was compared between cultures treated with 5
and 20 μg/ml of Hsp70, significant differences in neuronal
viability became apparent. RGCs treated with 20 μg/ml of
Hsp70 had lower numbers of RGC survival (40 ± 3%) than
RGCs treated with 5 μg/ml of Hsp70 (51 ± 1%, P < 0.05,
Figure 8A). To evaluate the contribution of PKC activity
in the observed Hsp70-dependent RGC death, we used
RGC/glia co-culture treated with 20 μg/ml of Hsp70 in
the presence of 10 μg/ml (7 μM) of PMB. Co-cultures
treated with Hsp70 only were used as controls. We found
that RGC cultures in the presence of a PKC inhibitor were
protected against treatment with Hsp70 and demonstrated
a reduced level of RGC death (53 ± 1% vs 40 ± 3%, P < 0.05)
(Figure 8B). These in vitro data suggest that extracellular
Hsp70 released as a result of ischemic stress can mediateneuronal death if there is PKC activity in glial cells. To
verify the observed results in vivo, the left eyes of WT and
Tlr4KO mice were intravitreally injected with Hsp70. The
contralateral eyes were treated with a vehicle and used as
controls. The retinas were collected seven days after treat-
ment and whole retina flat-mounts were stained for the
RGC marker beta III Tubulin to quantify the number of
surviving RGCs in the GCL (Figure 8C). We observed that
retinas from experimental eyes of WT mice had a signifi-
cantly higher percentage of dead RGCs (21 ± 3%) than the
Tlr4KO mice (4 ± 1%, P < 0.01, Figure 8D). To evaluate
the mechanism of Hsp70-mediated RGC death, we noted
that treatment of glial cells with Hsp70 induced signifi-
cant Tnf production (Figure 8E). It was shown previ-
ously that Tnf plays a largely deleterious role in retinal IR
injury [33]. To study the role of Tnf in Hsp70-mediated
RGC death, RGC/glia co-cultures were challenged with
20 μg/ml of Hsp70 in the presence or absence of XPro1595,
a selective soluble Tnf blocker. Levels of RGC survival in
these co-cultures were assessed 24 hours after treatment.
We found that treatment with Hsp70 only decreased the
number of live RGCs (40 ± 3%), while the RGC death was
reduced in the presence of XPro1595 (64 ± 5%, P < 0.01)
(Figure 8F). Thus, one way that extracellular Hsp70 can
Figure 7 PMB in Hsp70-treated astrocytes behaves as PKC inhibitor rather than endotoxin inhibitor. A) Pretreatment of astrocytes only
with the highest PMB concentration (10 μg/ml) caused significant reductions in the pro-inflammatory activity induced by the recombinant Hsp70,
while the pro-inflammatory response of LPS-treated astrocytes was significantly reduced by the addition of 1 and 10 μg/ml of PMB. Primary astrocytes
were treated with Hsp70 (5 μg/ml) containing 1.5 pg/ml of endotoxins or LPS (2.5 ng/ml) in the presence or absence of PMB (**P < 0.01, n = 6).
Differential expression of cytokines and chemokines was assessed in primary astrocytes after 24 hours by using quantitative RT-PCR. B) The amounts of
Tnf in culture media from astrocytes treated with Hsp70 (5 μg/ml) or LPS (2.5 ng/ml) in the presence or absence of PMB were measured by using
ELISA (**P < 0.01, *P < 0.05, n = 6). C) The level of Tnf was significantly reduced in media from astrocyte cultures treated with Hsp70 in the presence or
absence of PKC inhibitor (Gö6976, 10 nM and 100 nM). Culture media was collected 24 hours after treatment, and then the Tnf level was detected
using the ELISA kit (**P < 0.01, n = 6). Hsp70, heat shock protein 70; LPS, lipopolysaccharides PKC, protein kinase C; PMB, polymyxin B.
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cytotoxic levels of Tnf by glial cells.
Since Tlr4 signaling consists of two distinct signaling
cascades, Myd88- and Trif/Ripk1-dependent [10,34,35],
we evaluated the expression of Tlr4, Myd88, Trif and
Ripk1 in primary glial cells isolated from WT and Tlr4KO
animals and treated with 5 μg/ml of Hsp70 to identify cas-
cades involved in Hsp70-dependent neurotoxicity. We
found that the transcriptional levels of Tlr4 and Myd88
were increased in wild type astrocytes treated with Hsp70,
but not in microglia (Figure 9A). We also found no sig-
nificant changes in the expression of Trif and Ripk1
(Figure 9A). However, whereas astrocytes and micro-
glia expressed only a low level of Trif, they exhibited
significantly higher levels of Myd88 (Figure 9B). These
data suggest that the role of the Myd88 signaling cas-
cade may be more important in Hsp70-dependent pro-
inflammatory activation of glial cells than the role of the
Trif signaling cascade. To test this hypothesis, primary
glial cells were isolated from WT, Tlr4, Myd88- and Trif-
deficient animals, treated with Hsp70 as described above,
and then the Tnf levels were measured in the media of
these glial cells. We detected significantly reduced levels
of Tnf in media of Hsp70-treated Tlr4, Myd88- and Trif-
deficient glial cell cultures compared to glial cells isolated
from WT animals (Figure 9C). However, the level of Tnfin media of Hsp70-treated Myd88KO glial cells was re-
duced significantly compared to TrifKO glial cells treated
with Hsp70 (Figure 9C), which supports the hypothesis.
Discussion
Sterile inflammation, or innate immune response in the
absence of live pathogens, is an unavoidable conse-
quence of IR injury in the CNS, which jeopardizes the
viability of the neurons at the site of injury [1-3]. It has
been shown that IR-induced degenerative conditions can
be significantly improved by modulating the activity of
pro-inflammatory signaling cascades [1,36]. However, it
would be more effective to eliminate the triggers of ster-
ile inflammation rather than blocking their effector path-
ways. Many results obtained in vivo indicate that the
triggers of sterile inflammation are DAMPs, which are
released outside the cell following tissue injury, such as
injury induced by IR, and the subsequent activation of
pattern recognition receptors [8,9]. Tlr4 is a pattern rec-
ognition receptor that initiates an innate immune re-
sponse in the presence of bacteria-derived endotoxins
and DAMPs [9,10]. Importantly, the critical role of Tlr4
was shown in damage and sterile inflammation triggered
by IR in the CNS [11,12,37]. However, in vitro studies
suggest that DAMPs alone cannot activate Tlr4, and
thus additional factors should be involved in the DAMP-
Figure 8 Extracellular Hsp70 promotes RGC death by mediating production of cytotoxic levels of Tnf by glial cells. A) Recombinant
Hsp70 contributes to RGC death in vitro. RGC/glia co-cultures were treated 24 hours with 5 and 20 μg/ml of recombinant Hsp70, and RGC death
was detected by using the Apoptosis Assay Kit #2; (Invitrogen, United States). B) Inhibition of PKC activity in RGC/glia co-cultures with PMB helps
to protect RGCs from neurotoxicity mediated by Hsp70. RGC/glia co-cultures were treated 24 hours with 20 μg/ml of Hsp70 in the presence of 10
μg/ml of PMB or PBS (control) and then RGC death was detected. C) Representative confocal images of beta III Tubulin-labeled RGCs in the GCLs
(green) of flat-mounted retinas of eyes intravitreally injected with Hsp70 (1 μg per injection) and control eyes (vehicle treated; VT) were obtained
seven days after treatment. D) The percent of RGC death in control and Hsp70-treated eyes of WT and Tlr4KO animals (**P < 0.01, n = 6). E) Glial
cells treated with Hsp70 produce sufficient amounts of Tnf to initiate neuronal death. F) Treatment with Hsp70 increased RGC death in the RGC/glia
co-cultures, while treatment with Hsp70 in the presence of Tnf inhibitor (XPro1595) resulted in RGC protection. Hsp70, heat shock protein 70; PMB,
polymyxin B, PKC, protein kinase C; RGC, retinal ganglion cells.
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study, we focused on extracellular Hsp70, a prototypic
DAMP molecule and ligand of Tlr4, because it was re-
leased at high levels after IR in the retina. We tested
whether the presence of low endotoxin levels (subclin-
ical level, not leading to pro-inflammatory response) in
ischemic tissue or PKC activity were involved in Hsp70-
mediated pro-inflammatory neurotoxicity. Since activa-
tion of glial cells was shown to occur temporally before
leukocyte infiltration in ischemic tissue, we used primary
astrocyte and microglia cell cultures in our study. We
found that extracellular Hsp70 activates the Tlr4 signaling
cascade in glial cells that initiate the production of neuro-
toxic factors. PKC activity was critical to initiate the
Hsp70-dependent pro-inflammatory response. Meanwhile,
the low endotoxin levels were not involved in Hsp70-
mediated pro-inflammatory activity.
The concept that endotoxins can be involved in DAMP-
mediated pro-inflammatory activity became evident when
we noted that: 1) the presence of low endotoxin levels wasshown in human and animal tissues [18-21,38]; and 2) en-
dotoxins, even in small amounts, act in synergy and
amplify the DAMP-mediated pro-inflammatory response
[9,15-17,39]. It was suggested that the increased endotoxin
levels in tissues might be a result of endotoxin transloca-
tion derived from the resident bacteria in the gastrointes-
tinal tract [40-42]. However, detected endotoxin levels
were too low to have any pathological significance in
healthy tissue. At the same time, the low endotoxin levels
dramatically sensitize the immature brain to injury and in-
duce cerebral infarction in response to short periods of
hypoxia-ischemia [43]. In addition, an endotoxin inhibitor
can block heat exposure-induced expression of brain cyto-
kines [18]. Thus, DAMPs released as a result of patho-
logical conditions, such as IR, combined with a low-dose
endotoxin in the tissue could initiate a pro-inflammatory
response that promotes cell death and tissue damage.
Since it was shown in some studies that pure (endotoxin
free) DAMPs could not mediate a pro-inflammatory re-
sponse, the concept received our considerable attention.
Figure 9 Upon Hsp70 engagement, Tlr4 initiates a pro-inflammatory response via Myd88- and Trif-dependent signaling cascades.
A) Expression analysis of Tlr4 signaling cascade genes in Hsp70 (5 μg/ml) and PBS-treated glial cells demonstrated increased expression of Myd88
in wild type astrocytes (**P < 0.01, n = 6; WTa and WTm referred to WT astrocytes and WT microglia; Tlr4KOa and Tlr4KOm referred to Tlr4KO
astrocytes and Tlr4KO microglia). B) A comparative analysis of Tlr4, Myd88, Trif, Ripk1 gene expression in wild type and Tlr4KO glial cells suggests
the preferential activation of Myd88 signaling cascade. C) The amount of Tnf in culture media from wild type, Tlr4KO, Myd88KO and TrifKO glial
cells treated with Hsp70 and PBS (control) (**P < 0.01, n = 6). D) Two main downstream branches of Tlr4 signaling. Hsp70, heat shock protein 70;
PBS, phosphate buffering saline; WT, wild type.
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in our study [22]. We found significant neuroprotec-
tion and a reduced pro-inflammatory response in is-
chemic retinas as a result of PMB treatment. However,
we did not detect any endotoxin presence in the studied
tissues. We also noted that in the cited papers, endo-
toxin levels were within the sensitivity range of the
assay used. In addition, Rivera et al. [21] detected endo-
toxins in the portal vein but not the vena cava, showing
endotoxins to be present in blood coming from the
gastrointestinal tract to the liver, and then being de-
toxified in the liver before being distributed to the
rest of the body. It is therefore hard to conclude whether
the neuroprotective effect of PMB in vivo is due to inhib-
ition of undetectable levels of endotoxin, or other effects
that are unrelated to endotoxins. PMB is also a PKC in-
hibitor [23-25], and thus, the in vivo protective effects
could be due to inhibition of PKC. To test this hypothesis
we treated the animals with a known PKC inhibitor
(Gö6976) and found significant neuroprotection. There-
fore, the neuroprotective effect in PMB-treated ischemic
retinas should be due to PKC inhibition rather than endo-
toxin inhibition.The universally expressed PKC family in vertebrate tis-
sues is involved in many signaling cascades, including
the innate immune response [26,44]. PKC isozymes mod-
ify other proteins by chemically adding phosphate groups
to them from a nucleoside triphosphate (ATP) and are
classified as conventional, novel and atypical [26,44,45].
Conventional PKC isozymes are Ca2+-dependent, while
novel and atypical isozymes do not require Ca2+ for their
activation. In our study, we used PKC inhibitors, which in-
hibit predominantly conventional PKC isozymes. Many
PKC isozymes, including conventional ones, were identi-
fied in the retina and were activated as a result of IR [46].
Since: 1) PKC family is directly involved in the Tlr4-
mediated innate immune response [26]; 2) PKC inhibitors
reduce retinal damage and inflammation and; 3) release of
Hsp70, a known DAMP and ligand of Tlr4 [3,9], was ob-
served after retinal IR, we hypothesized that Hsp70 re-
leased as a result of IR activates Tlr4 and initiates a
neurotoxic pro-inflammatory response in the presence of
PKC activity. To test this hypothesis, we turned to cell cul-
tures. We used Hsp70 containing low-dose endotoxin.
However, since endotoxins were still present in Hsp70
preparations, we have taken all precautions to properly
Figure 10 Proposed mechanism of extracellular Hsp70-mediated
neurotoxic pro-inflammatory response in tissue after IR.
The initial ischemic stress followed by reperfusion leads to the cell
injury (necrosis) and the release of Hsp70. That same ischemic
stress (increase in intracellular Ca2+) and reperfusion (increase in
ATP (adenosine triphosphate)) mediate PKC activation. These two
events are the necessary and sufficient conditions for activation of Tlr4
signaling and production of neurotoxic levels of pro-inflammatory
factors such as Tnf. This pro-inflammatory response can trigger further
tissue damage leading to increasing levels of extracellular Hsp70. Thus,
a cycle may be repeated many times, which can result in significant
tissue damage after IR. ATP, Hsp70, heat shock protein 70; IR, ischemic
reperfusion; PKC, protein kinase C.
Dvoriantchikova et al. Journal of Neuroinflammation 2014, 11:81 Page 14 of 16
http://www.jneuroinflammation.com/content/11/1/81interpret the data. We found that the presence of native
Hsp70 was critical in Tlr4-dependent innate immune
response and PKC inhibitors reduced Hsp70-mediated
production of pro-inflammatory factors. Importantly,
LPS-activated cells behaved as if PMB inhibits LPS and
PKC, while Hsp70-activated cells behaved as if PMB in-
hibits only PKC and the presence of low endotoxin levels
has no role to play. Thus, these data suggest that PKC ac-
tivity, but not low-dose endotoxin presence, is critical to
mediate an Hsp70-dependent pro-inflammatory response.
Taken together, we can suggest that PKC activation as
a result of ischemia (increase in intracellular Ca2+) re-
perfusion (increase ATP) [46,47] and increase of extra-
cellular Hsp70 as a result of tissue damage promotes the
activation of Tlr4 signaling that initiates a neurotoxic
pro-inflammatory response (Figure 10). It is known that
Myd88 and Trif adaptor proteins modulate the Tlr4 sig-
naling pathway [10,35]. Our data suggests that the
Myd88 signaling cascade is probably more important in
Hsp70-dependent pro-inflammatory activation of glial
cells than the Trif signaling cascade. We also demon-
strated that Hsp70 mediates activation of NF-κB tran-
scription factor, which initiates transcription of genes
coding proteins such as cytokines, chemokines, and ROS
producing enzymes, which can mediate cell death and
promote tissue damage [48]. We have found that Hsp70-
treated astrocytes are a primary source of chemokines,and thus can facilitate leukocyte infiltration in the ische-
mic tissue. At the same time, Hsp70-activated microglia
may be responsible mainly for ROS production. Both
types of glial cells release Tnf and produce the immature
form of Il1b in a Tlr4-dependent manner in the presence
of Hsp70. Collectively, all these factors can mediate neur-
onal toxicity, which was observed previously [28,33,49].
Our in vivo and in vitro data indicate that one way that
extracellular Hsp70 can promote neuronal death is by me-
diating production of cytotoxic levels of Tnf by glial cells.
Importantly, in contrast to the data above, intracellular
Hsp70 assists protein-folding processes in all cells, and
helps to protect neurons from ischemic stress [31,32].
However, the results presented in this study suggest that
high levels of extracellular Hsp70 released as a result of is-
chemic stress in tissue can initiate a strong neurotoxic
pro-inflammatory response, which far exceeds the neuro-
protective activity of Hsp70.
Conclusions
In this study we describe for the first time the molecular
mechanism of extracellular Hsp70 pro-inflammatory ac-
tivity in the retina after IR. Our findings indicate that
Hsp70 can mediate Tlr4-dependent innate immune re-
sponse only if PKC activity is present. This data is of great
significance because lately there have been doubts regard-
ing the ability of pure DAMPs (extracellular Hsp70 is
one of them) to initiate an innate immune response. The
mechanism described here can offer insights on the ability
of many other DAMPs to mediate innate immune re-
sponse in ischemic tissue, and may be helpful for the de-
velopment of new drugs against IR injury.
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